celecoxib has been researched along with Esophagitis in 3 studies
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our patient had severe esophagitis caused by Celecoxib and aggravated by reflux of achlorhydric gastric contents after dilatation of the stricture." | 7.72 | Celecoxib associated esophagitis: review of gastrointestinal side effects from cox-2 inhibitors. ( Mantry, P; Shah, A; Sundaram, U, 2003) |
| " The main toxicities were grades 1 and 2 nausea and esophagitis, and they were independent of the dose of celecoxib or radiotherapy schedule." | 5.11 | A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. ( Blumenschien, G; Brown, B; Chang, JY; Cox, JD; Fossella, F; Guerrero, T; Jeter, M; Kies, M; Komaki, R; Liao, Z; Milas, L; Smith, CM; Yuan, C, 2005) |
| " Our patient had severe esophagitis caused by Celecoxib and aggravated by reflux of achlorhydric gastric contents after dilatation of the stricture." | 3.72 | Celecoxib associated esophagitis: review of gastrointestinal side effects from cox-2 inhibitors. ( Mantry, P; Shah, A; Sundaram, U, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mantry, P | 1 |
| Shah, A | 1 |
| Sundaram, U | 1 |
| Lugardon, S | 1 |
| Lapeyre-Mestre, M | 1 |
| Montastruc, JL | 1 |
| Liao, Z | 1 |
| Komaki, R | 1 |
| Milas, L | 1 |
| Yuan, C | 1 |
| Kies, M | 1 |
| Chang, JY | 1 |
| Jeter, M | 1 |
| Guerrero, T | 1 |
| Blumenschien, G | 1 |
| Smith, CM | 1 |
| Fossella, F | 1 |
| Brown, B | 1 |
| Cox, JD | 1 |
1 trial available for celecoxib and Esophagitis
| Article | Year |
|---|---|
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cohort Studies; Combined | 2005 |
2 other studies available for celecoxib and Esophagitis
| Article | Year |
|---|---|
Celecoxib associated esophagitis: review of gastrointestinal side effects from cox-2 inhibitors.
Topics: Aged; Aged, 80 and over; Celecoxib; Cyclooxygenase Inhibitors; Esophageal Stenosis; Esophagitis; Hum | 2003 |
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo | 2004 |